Mini-Networking Night: Research and Development


Date - 05/12/2018
6:00 pm - 8:00 pm


Prenup Pub, 191 College Street, Toronto,

Mini-Networking Night: Research and Development

Event details:

Are you interested in innovative research opportunities after completing your graduate degree? Join us on December 5th, 2018 to learn from the guests working in the R&D sector. Featuring guests from: BlueRock Therapeutics, Sanofi Pasteur, Mannin Research (JLABS), Northern Biologics, and Trillium Therapeutics! They are happy to share their experience and advice on how to advance your career and join an industrial R&D. We welcome everyone interested to register and participate in this networking event. Take advantage of this opportunity to talk to scientists from some of the most innovative companies in Toronto.

Date: Wednesday, December 5st, 2018

Registration: Opens on November 27th, 2018

Time: 6:00 – 8:00 pm
Location: Prenup Pub (191 College St., ), Second Floor.

Event program

6:00 – 6:30 p.m. Registration

6:30 – 6:35 p.m. Welcome remarks & Guest introduction

6:35 – 7:35 p.m. Structured Networking (students are organized into groups, which 3x rotate every 20 minutes)

7:35 – 8:00 p.m. Open Networking

*Appetizers & cash bar are provided.

Note: Please follow us on social media (FacebookLinkedIn and Twitter). The call for registration for all events in the Mini-Networking Series will first go out on social media.

Very limited space available. Registered individuals who do not show up will be prevented from registering for future events.

The Mini-Networking Series is free for all students, post-docs and other research trainees at the University of Toronto or the affiliated research institutions. External participants must pay a $10 fee to register.

Have more questions about registration? Visit our FAQ page.

***Note: Ticket for U of T students and trainees are free and available to logged in users.***

Guests for this event:

Tony D’Amore, Ph.D. MBA – Vice President, Product Research and Development – Sanofi Pasteur

Philipe Gobeil, Ph.D. – Principal Scientist – Northern Biologics

Bob McGray, PhD. – Senior Scientist – Northern Biologics

Lisa Johnson, Ph.D. – Senior Scientist, Group Leader Translational Research – Trillium Therapeutics Inc

Attila Szabo, BSc – Research Scientist – BlueRock Therapeutics

Varvara Gagarina, MSc. – Research Laboratory Technician – Mannin Research


Guests Bio:

 Tony D’Amore, Ph.D. MBARelated image

Tony is currently the Vice-President, Global Product Research & Development, responsible for leading a global group involved in process and analytical development leading to Phase I and Phase II manufacture of clinical trial material and the delivery of clinical supplies to the clinical trial sites, to support the Sanofi Pasteur new vaccine project portfolio.
Tony joined Sanofi Pasteur in 1994 (then Connaught Laboratories) as a Purification Scientist. He has taken on successive leadership positions including the Vice-President of Bioprocess Research and Development North America at Sanofi Pasteur, responsible for process development and the manufacture of clinical trial material.
He holds a PhD in Biochemistry from the University of Windsor and a MBA from Wilfred Laurier University.


 Philipe Gobeil, Ph.D. Related image

Phil received his PhD from the Western College of Veterinary Medicine in Veterinary Microbiology and completed post-doctoral training at the University of Glasgow School of Veterinary Medicine in Scotland and at Dartmouth College in New Hampshire.
In 2012 Phil joined ImmuNext, a start-up company spun out of an immunology-focused academic lab from Dartmouth. Here, Phil was tasked with developing and testing large molecule therapeutics targeting a novel immune checkpoint for use in oncology. In three years the ImmuNext team took their therapeutic from target validation to the clinic. With the successful translation of this therapeutic to the clinic, Phil returned to discovery phase drug development, leading a program to use large molecule therapeutics to modulate tumor immunometabolism.
In 2016 Phil joined Northern Biologics as Principal Scientist- Immune-Oncology, returning to Canada after ten years abroad. At Northern Biologics he leads a team in developing pre-clinical therapeutics aimed at modulating the immune system for use in oncology. As part of his role he also works with the business development team, conducting scientific due-diligence for in-licensing opportunities.

 Bob McGray, Ph.D.  Related image

Bob completed his BSc. in Biological sciences and MSc. in Medical sciences at the University of Guelph. He then completed his PhD. at McMaster University focusing on tumour response to cancer immunotherapy. After his PhD, he continued studying cancer immunotherapy strategies as a Post-doctoral fellow at Roswell Park Cancer Institute. He now works as a Senior Scientist at Northern Biologics.


 Lisa Johnson, Ph.D. Related image

Lisa obtained her PhD training from the University of Minnesota, specializing in microbiology, immunology, and cancer biology. She completed her post-doctoral training at BC Cancer Agency, where she initiated a translational research program in immune modulation and radiotherapy, in collaboration with radiation oncologists and medical physicists.

Lisa designed and carried out a prospective study of 350 prostate cancer patients receiving radiotherapy in order to characterize adaptive responses to radiation therapy. She first started at Trillium Therapeutics Inc. in 2015 as a research scientist, responsible for design and implementation of biomarker and pharmacodynamic assessments in immuno-oncology clinical trials. She currently holds a position of senior scientist and group leader in translational research.


 Attila Szabo, B.Sc. Related image

Attila is currently the Research Technician at BlueRock Therapeutics. He completed his BSc at the University of Toronto Molecular Genetics department and held numerous laboratory research positions that provided him with experimental and analytical experience, with a strength in protein-related assays and mammalian cell model systems.

Attila also served as a lab manager and president of BORDERLESS, a non-profit campus organization that aims to bring awareness to under reported humanitarian situations around the world. He gained. He is passionate about utilizing the scientific method to uncover the causes for widespread diseases and the age-related degradation of the body.


 Varvara Gagarina, M.Sc. Related image

Having recently graduated from York University, I am now part of a start-up biotechnology company that researches and aims to develop novel therapeutics for Primary Open-Angle Glaucoma and other vascular diseases. I hold a BSc (Hon) in Biochemistry and MSc in Molecular and Structural Biology.
My cumulative academic and industry experience includes more than four years of research in biology laboratories, university-level teaching, and business administration. During my studies I also tutored, mentored, and organized events for students as a community activist with Bethune College and the Association of Graduate Students in Biological Sciences (AGSBS). I’m excited to share the story of my career path with students looking to gain a foothold in the life sciences industry.



Bookings are closed for this event.